Prospective studies performed by The Endogenous Hormones and Breast Cancer Collaborative Group39 have shown that women with the highest concentration of IGF1 have a 28% higher risk of developing breast cancer than women with the lowest concentration. The gene discussed is IGF1; the disease is breast carcinoma.